NextPage

NextPage is an early-stage spatial biology company dedicated to advancing the field of high-resolution tissue mapping and molecular analysis. Founded by veterans of 10x Genomics, including former CTO Michael Schnall-Levin, the company is developing a next-generation platform designed to overcome the resolution and throughput limitations of current spatial transcriptomics and proteomics tools. Their technology integrates innovative chemistry, hardware, and computational methods to provide a comprehensive view of cellular interactions within their native tissue environments. By enabling precise visualization of gene and protein expression, NextPage aims to empower researchers in oncology, immunology, and neuroscience to discover new biomarkers and therapeutic targets. The company is headquartered in Pleasanton, California, and operates as a private, venture-backed entity focused on providing the next level of biological context at the single-cell level.